111In-NLS-HuM195 exhibited 2-fold greater potency than 111In-HuM195 without NLS for killing HL-60 human myeloid leukemia cells in vitro, and also decreased the clonogenic survival of CD33-positive primary patient AML specimens (Chen et al. 2006). Here, CD33 is linked to acute myeloid leukemia.